Steven Cohen's DGX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 23,380 shares of Quest Diagnostics Incorporated (DGX) worth $4.96 M, representing 0.01% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in DGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 678,163 shares. Largest reduction occurred in Q3 2023, reducing 971,123 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Quest Diagnostics Incorporated (DGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Quest Diagnostics Incorporated (DGX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +23,380 | New Buy | 23,380 | $211.95 |
| Q1 2026 | -100,301 | Sold Out | 0 | $0.00 |
| Q4 2025 | +100,301 | New Buy | 100,301 | $173.53 |
| Q3 2024 | -299,740 | Sold Out | 0 | $0.00 |
| Q2 2024 | +206,640 | Add 221.95% | 299,740 | $136.88 |
| Q1 2024 | -49,269 | Reduce 34.61% | 93,100 | $133.11 |
| Q4 2023 | +142,369 | New Buy | 142,369 | $137.88 |
| Q3 2023 | -971,123 | Sold Out | 0 | $0.00 |
| Q2 2023 | +678,163 | Add 231.49% | 971,123 | $140.56 |
| Q1 2023 | -238,238 | Reduce 44.85% | 292,960 | $141.48 |
| Q4 2022 | +531,198 | New Buy | 531,198 | $156.44 |
| Q3 2022 | -42,659 | Sold Out | 0 | $0.00 |
| Q2 2022 | +42,659 | New Buy | 42,659 | $132.98 |
| Q3 2020 | -1,500 | Sold Out | 0 | $0.00 |
| Q2 2020 | +1,500 | New Buy | 1,500 | $114.00 |
| Q1 2019 | -150,000 | Sold Out | 0 | $0.00 |
| Q4 2018 | +150,000 | New Buy | 150,000 | $83.27 |
| Q1 2018 | -56,000 | Sold Out | 0 | $0.00 |
| Q4 2017 | +56,000 | New Buy | 56,000 | $98.48 |
| Q3 2017 | -24,500 | Sold Out | 0 | $0.00 |
| Q2 2017 | +24,500 | New Buy | 24,500 | $111.14 |
| Q3 2014 | -155,400 | Sold Out | 0 | $0.00 |
| Q2 2014 | +155,400 | Add 0.00% | 155,400 | $58.69 |
Steven Cohen's Quest Diagnostics Incorporated Investment FAQs
Steven Cohen first purchased Quest Diagnostics Incorporated (DGX) in Q2 2014, acquiring 155,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Quest Diagnostics Incorporated (DGX) for 23 quarters since Q2 2014.
Steven Cohen's largest addition to Quest Diagnostics Incorporated (DGX) was in Q2 2023, adding 971,123 shares worth $136.5 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 23,380 shares of Quest Diagnostics Incorporated (DGX), valued at approximately $4.96 M.
As of the Q2 2026 filing, Quest Diagnostics Incorporated (DGX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Quest Diagnostics Incorporated (DGX) was 971,123 shares, as reported at the end of Q2 2023.